Phase III Trial Opens: Continuous Glucose Monitoring-Based Lifestyle Program vs Standard Care in Early Type 2 Diabetes — What Clinicians Need to Know

References

1. 1.Fabris, C. (2023). Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification. ClinicalTrials.gov. NCT05766735. https://clinicaltrials.gov/study/NCT05766735
2. 2.Davies, M. J., Aroda, V. R., Collins, B. S., Gabbay, R. A., Green, J., Maruthur, N. M., Rosas, S. E., Del Prato, S., Mathieu, C., Mingrone, G., Rossing, P., Tankova, T., Tsapas, A., & Buse, J. B. (2022). Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care, 45(11), 2753-2786. https://doi.org/10.2337/dci22-0034
3. 3.Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., Toschi, E., Wolpert, H., & Price, D. (2017). Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes. JAMA, 317(4), 371-378. https://doi.org/10.1001/jama.2017.10833
4. 4.Monnier, L., Mas, E., Ginet, C., Michel, F., Villon, L., Cristol, J. P., & Colette, C. (2006). Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA, 295(14), 1681-1687. https://doi.org/10.1001/jama.295.14.1681
5. 5.Magliano, D. J., Sacre, J. W., Harding, J. L., Gregg, E. W., Zimmet, P. Z., & Shaw, J. E. (2020). Young-onset type 2 diabetes mellitus — implications for morbidity and mortality. Nature Reviews Endocrinology, 16(6), 321-331. https://doi.org/10.1038/s41574-020-0334-z